Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer

Published:2019-01-11 Issue:3 Volume:23 Page:2077-2082
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Xu Chunhua¹²³^ORCID,Wang Yuchao¹²³,Yuan Qi¹²³,Wang Wei¹²³,Chi Chuanzhen¹²³,Zhang Qian¹²³,Zhang Xiuwei⁴

Affiliation:

1. Endoscopic Center of Nanjing Chest Hospital; Nanjing Jiangsu China

2. Clinical Center of Nanjing Respiratory Diseases and Imaging; Nanjing Jiangsu China

3. Department of Respiratory Medicine; Nanjing Chest Hospital; Nanjing Jiangsu China

4. Department of Respiratory Medicine; Affiliated Jiangning Hospital of Nanjing Medical University; Nanjing Jiangsu China

Funder

Major Program of Nanjing Medical Science and Technique Development Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.14116/fullpdf

Reference22 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer;Maddison;Lung Cancer,2010

3. Small cell lung cancer-state of the art and future perspectives;J Barata;Rev Port Pneumol,2007

4. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

5. Lung cancer outcomes at a UK cancer unit between 1998-2001;Free;Lung Cancer,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer;Heliyon;2024-01

2. Natural products targeting tumour angiogenesis;British Journal of Pharmacology;2023-10-05

3. Evaluating the diagnostic and prognostic value of serum TuM2‐PK, NSE, and ProGRP in small cell lung cancer;Journal of Clinical Laboratory Analysis;2023-04

4. Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma;International Journal of Molecular Sciences;2023-02-14

5. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection;Journal of Thoracic Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3